A phase I study of olaparib in combination with capecitabine-based chemoradiation (CRT) in patients (pts) with locally advanced pancreatic cancer (LAPC). (2020)
Attributed to:
Glasgow Molecular Pathology (GMP) Node
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1200/jco.2020.38.4_suppl.709
Publication URI: http://dx.doi.org/10.1200/jco.2020.38.4_suppl.709
Type: Journal Article/Review
Parent Publication: Journal of Clinical Oncology
Issue: 4_suppl